New “Map” Shows How Cells Move in Response to Protein Bursts
April 6, 2016—(BRONX, NY)—A team of researchers at Einstein have created "maps" that colorfully illustrate the influence of the protein Rac2 in forming protrusions that allow mouse macrophages to migrate. The research is described in the April 15, 2016 print edition of The Journal of Immunology, whose cover image is taken from the study. The co-senior authors were Louis Hodgson, Ph.D., associate professor of anatomy & structural biology, and Dianne Cox, Ph.D., professor of anatomy & structural biology and of developmental & molecular biology. Both are members of the Gruss Lipper Biophotonics Center....
Source: Einstein News - April 6, 2016 Category: Universities & Medical Training Source Type: news

Susan Band Horwitz to Deliver Einstein's 2016 Commencement Address
March 23, 2016—(BRONX, NY)—Cancer researcher and molecular pharmacologist Susan Band Horwitz, Ph.D., will deliver the keynote address at the 2016 commencement ceremony for Albert Einstein College of Medicine. Dr. Horwitz, distinguished professor of molecular pharmacology at Einstein, is best known for discovering the mechanism of action of Taxol, the first “blockbuster” drug to treat ovarian and breast cancer. Einstein’s graduation ceremony will take place Wednesday, May 25 at 6 p.m. at Lincoln Center’s David Geffen Hall. (Source: Einstein News)
Source: Einstein News - March 24, 2016 Category: Universities & Medical Training Source Type: news

Match Day Marks New Beginnings for Einstein's Class of 2016
March 18, 2016—(BRONX, NY)—Every March, graduating medical school students around the country learn where they will spend their residency during Match Day ceremonies. Earlier today, Einstein’s class of 2016 capped their years of hard work by celebrating their successful matches with family and friends. (Source: Einstein News)
Source: Einstein News - March 18, 2016 Category: Universities & Medical Training Source Type: news

Women May Keep Verbal Memory Skills Longer than Men in the Early Stages of Alzheimer's
RELEASE ISSUED BY: American Academy of Neurology (Source: Einstein News)
Source: Einstein News - March 16, 2016 Category: Universities & Medical Training Source Type: news

Montefiore and Einstein Are Tapped by the White House for Precision Medicine Initiative
NEW YORK (February 25, 2016) — Montefiore Health System and Albert Einstein College of Medicine have been selected to be part of the White House’s inaugural Precision Medicine Initiative Summit. Parsa Mirhaji, M.D., Ph.D., director of Clinical Research Informatics at Montefiore and Einstein is among an elite group of healthcare leaders from across the country who will participate in a roundtable today at the White House. The event will focus on efforts to integrate biological, clinical, environmental, and administrative data to advance innovations in research and improve the delivery of healthcare. (Source: Einstein News)
Source: Einstein News - February 25, 2016 Category: Universities & Medical Training Source Type: news

Protein That Triggers Juvenile Arthritis Identified
February 25, 2016—(BRONX, NY)—Juvenile idiopathic arthritis, or JIA, is the most common form of childhood arthritis. It appears to be an autoimmune disease, caused by antibodies attacking certain proteins in a person’s own tissue. But no “autoantigens”—the proteins triggering an immune attack—have been linked to JIA. (Source: Einstein News)
Source: Einstein News - February 25, 2016 Category: Universities & Medical Training Source Type: news

Overdose Deaths from Common Sedatives Have Surged, New Study Finds
February 18, 2016—(BRONX, NY)—Headlines about America’s worsening drug epidemic have focused on deaths from opioids—heroin and prescription painkillers such as OxyContin. But overdose deaths have also soared among the millions of Americans using benzodiazepine drugs, a class of sedatives that includes Xanax, Valium, and Klonopin, according to a study led by researchers at Albert Einstein College of Medicine, Montefiore Health System and the Perelman School of Medicine at University of Pennsylvania. Their findings appear online today in the American Journal of Public Health. (Source: Einstein News)
Source: Einstein News - February 18, 2016 Category: Universities & Medical Training Source Type: news

New Study Finds Interruption of Radiation Therapy Risks Cancer Recurrence
February 9, 2016—(NEW YORK, NY)—Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators at Montefiore Einstein Center for Cancer Care (MECCC) and Albert Einstein College of Medicine’s NCI–designated Albert Einstein Cancer Center have found. The study, published in the International Journal of Radiation Oncology Biology Physics, suggests that this noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes...
Source: Einstein News - February 9, 2016 Category: Universities & Medical Training Source Type: news